Treatment of thyroid cancer based on risk groups

Journal of Surgical Oncology

Volumn 94, Issue 8, 2006, Pages 683-691

  Shaha, Ashok ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Risk group; Thyroid cancer; Treatment

Indexed keywords

AGE DISTRIBUTION; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SURGERY; DIFFERENTIAL DIAGNOSIS; HIGH RISK BEHAVIOR; HISTOPATHOLOGY; HUMAN; MEDICAL DECISION MAKING; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; THYROID CANCER; THYROIDECTOMY; TREATMENT PLANNING; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; AGED; BIOPSY, FINE-NEEDLE; BRAIN NEOPLASMS; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENTAL FINDINGS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 33845455129     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20697     Document Type: Review

References (34)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
2. Hundahl SA, Fleming ID, Fremgen AM, et al.: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998;83:2638-2648.
3. Shaha AR: Controversies in the management of thyroid nodule. Laryngoscope. 2000;110:183-193.
4. Walsh RM, Watkinson JC, Franklyn J: The management of the solitary thyroid nodule: A review. Clin Otolaryngol 1999;24:388-397.
5. Hay ID, Grant CS, Taylor WF, et al.: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
6. Hay ID, Bergstralh EJ, Goellner JR, et al.: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;104:947-953.
7. Brierley JD, Panzarella T, Tsang RW, et al.: Review. A comparison of different staging systems predictability of patient outcome: Thyroid carcinoma as an example. Cancer 1997;79:2414-2423.
8. Shaha AR, Loree TR, Shah JP: Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131-1138.
9. Byar DP, Green SB, Dor P, et al.: A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-1041.
10. Cady B: Hayes Martin Lecture. Our AMES is true: How an old concept still hits the mark, or risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997;174:462-468.
11. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-953.
12. Pasieka JL, Zedenius J, Auer G, et al.: Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992;112:1154-1160.
13. Schindler A, et al.: Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324-330.
14. Shah JP, et al.: Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-661.
15. Simpson WJ, et al.: Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients. Am J Med 1987;83:479-488.
16. Coburn MC, Wanebo HJ: Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992;164:671-676.
17. Shaha AR, Shah JP, Loree TR: Low-risk differentiated thyroid cancer: The need for selective treatment. Ann Surg Oncol 1997;4:328-333.
18. Clark OH: Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982;196:361-370.
19. Hughes CJ, Shaha AR, Shah JP, et al.: Impact of lymph node metastasis in differentiated carcinoma of the thyroid - A matched pair analysis. Head & Neck 1996;18:127-132.
20. Tubiana M, et al.: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
21. Cunningham MP, et al.: Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;16:344-347.
22. Noguchi M, et al.: Multivariate study of prognostic factors of differentiated thyroid carcinoma: The significance of histologic subtype. Int Surg 1993;78:10-15.
23. Mazzaferri EL: Review. Papillary thyroid carcinoma: Factors influencing prognosis and current therapy. Semin Oncol 1987;14:315-332.
24. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
25. Sugitani I, Kasai N, Fujimoto Y, et al.: A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139-148.
26. Czaja JM, McCaffrey TV: The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:484-490.
27. Grillo HC, Zannini P: Resectional management of airway invasion by thyroid carcinoma. Ann Thorac Surg 1986;42:287-298.
28. McCaffrey TV, Bergstralh EJ, Hay ID: Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck 1994;16:165-172.
29. Anderson PE, et al.: Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 1995;170:467-470.
30. Gilliland FD, Hunt WC, Morris DM, et al.: Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program, 1973-1991. Cancer 1997;79:564-573.
31. Cady B: Staging in thyroid carcinoma. Cancer 1998;83:844-847.
32. Sherman SI, Brierley JD, Sperling M, et al.: Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83:1012-1021.
33. Hay ID, Grant CS, Bergstralh EJ, et al.: Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-966.
34. Wong JB, Kamplan MN, Meyer KB, et al.: Ablative radioactive iodine therapy for apparently localized thyroid carcinoma: A decision analytic perspective. Endocrinol Metab Clin North Am 1990;19:741-760.